Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 3.60 Delayed Data As of 4:00pm ET |  +0.13 / +3.75%Today’s Change | 1.90 Today|||52-Week Range 4.70 | +41.45% Year-to-Date |
Latest NLTX News | Press Releases
No recent news for Neoleukin Therapeutics Inc.
Today’s Trading
| Previous close | 3.47 |
| Today’s open | 3.60 |
| Day’s range | 3.53 - 3.60 |
| Volume | 25 |
| Average volume (3 months) | 31,747 |
| Market cap | $37.6M |
Data as of 4:00pm ET, 12/07/2023
Growth & Valuation
| Earnings growth (last year) | +5.48% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLSSellas Life Sciences... | -0.02 | -1.94% |
| SLGLSol Gel Technologies... | +0.01 | +0.85% |
| ---- | ||
| --Nicox SA | 0.00 | 0.00% |
Data as of 3:58pm ET, 12/07/2023
Financials
| Last reporting date | August 16, 2023 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$57.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
